Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  225.95
-4.33 (-1.88%)
AAPL  277.96
-0.07 (-0.03%)
AMD  210.26
-11.17 (-5.04%)
BAC  54.83
+0.27 (0.49%)
GOOG  308.87
-4.83 (-1.54%)
META  640.32
-12.39 (-1.90%)
MSFT  478.04
-5.43 (-1.12%)
NVDA  176.02
-4.91 (-2.71%)
ORCL  187.84
-11.00 (-5.53%)
TSLA  443.94
-2.95 (-0.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.